Lava Therapeutics Nv Reports Results For The Quarter Ended In June: Earnings Summary

LAVA Therapeutics NV

16/08/2021 13:32

* LAVA Therapeutics NV  LVTX.OQ  reported a quarterly adjusted
loss of 28 cents​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 27 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* LAVA Therapeutics NV's reported EPS for the quarter was a loss
of 28 cents​.
* The mean earnings estimate of analysts had fallen by
about 4.7% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* LAVA Therapeutics NV shares had fallen by 47.5% this quarter.
* The company reported a quarterly loss of $6.97 million.
* Wall Street's median 12-month price target for LAVA
Therapeutics NV is $23.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 16 at 12:32 p.m.  ​All
figures in US dollars unless otherwise stated